Private equity giant Advent International has positioned itself at the forefront of the emerging animal health generics market through a $175 million strategic investment in Ireland-based Felix...
Edinburgh-based healthcare SaaS provider Craneware has rebuffed a £26.50-per-share acquisition proposal from Bain Capital, asserting the $1.3 billion valuation fundamentally misprices its market...
UnitedHealth Group's potential $1 billion divestiture of its Banmedica subsidiary marks a pivotal moment in corporate strategy realignment, reflecting both sector-specific challenges and broader...
The mutual termination of Owens & Minor's proposed $1.36 billion acquisition of Rotech Healthcare marks a pivotal moment in the home medical equipment sector, exposing regulatory landmines in...
French beauty conglomerate L'Oréal stands poised to finalize one of 2025's most significant beauty acquisitions with its €1 billion purchase of UK clinical skincare pioneer Medik8 . This...
In a landmark move with national implications, Oregon lawmakers passed Senate Bill 951 on May 28, 2025, enacting the most comprehensive state-level restrictions on corporate control of medical...
Sanofi's landmark $9.1 billion acquisition of Blueprint Medicines marks a pivotal shift in the global biopharma landscape, combining immediate revenue generation with long-term immunology pipeline...
As healthcare systems grapple with post-pandemic financial pressures and evolving care delivery models, Ascension Health's potential $3.9 billion acquisition of AmSurg represents a watershed moment...
The telehealth sector witnessed a transformative move on June 3, 2025, as Hims & Hers Health (NYSE: HIMS) announced its acquisition of ZAVA, a leading European digital health platform. This $1.2...
As Merck & Co. confronts the impending 2028 patent expiration of its $29.5 billion oncology blockbuster Keytruda, the pharmaceutical giant's reported $3 billion pursuit of MoonLake...
